A very high level of crossreactivity is an essential feature of the T-cell receptor - PubMed (original) (raw)

Review

A very high level of crossreactivity is an essential feature of the T-cell receptor

D Mason. Immunol Today. 1998 Sep.

No abstract available

PubMed Disclaimer

Comment in

• Crossreactivity of the T-cell receptor.
  Borghans JA, De Boer RJ. Borghans JA, et al. Immunol Today. 1998 Sep;19(9):428-9. doi: 10.1016/s0167-5699(98)01317-6. Immunol Today. 1998. PMID: 9745208 No abstract available.

Similar articles

• Crossreactivity of the T-cell receptor.
  Borghans JA, De Boer RJ. Borghans JA, et al. Immunol Today. 1998 Sep;19(9):428-9. doi: 10.1016/s0167-5699(98)01317-6. Immunol Today. 1998. PMID: 9745208 No abstract available.
• Self-help in T cell recognition?
  Bakker TR, van der Merwe PA. Bakker TR, et al. Nat Immunol. 2002 Jan;3(1):11-2. doi: 10.1038/ni0102-11. Nat Immunol. 2002. PMID: 11753401 No abstract available.
• Viral decoy vetoes killer cell.
  Kärre K, Welsh RM. Kärre K, et al. Nature. 1997 Apr 3;386(6624):446-7. doi: 10.1038/386446a0. Nature. 1997. PMID: 9087399 No abstract available.
• [Molecular recognition by immunologically relevant receptors].
  Maenaka K. Maenaka K. Tanpakushitsu Kakusan Koso. 2001 Aug;46(11 Suppl):1805-11. Tanpakushitsu Kakusan Koso. 2001. PMID: 11579582 Review. Japanese. No abstract available.
• Self-antigen presentation by thymic stromal cells: a subtle division of labor.
  Klein L, Kyewski B. Klein L, et al. Curr Opin Immunol. 2000 Apr;12(2):179-86. doi: 10.1016/s0952-7915(99)00069-2. Curr Opin Immunol. 2000. PMID: 10712940 Review.

Cited by

• HLA A*24:02-restricted T cell receptors cross-recognize bacterial and preproinsulin peptides in type 1 diabetes.
  Dolton G, Bulek A, Wall A, Thomas H, Hopkins JR, Rius C, Galloway SA, Whalley T, Tan LR, Morin T, Omidvar N, Fuller A, Topley K, Hasan MS, Jain S, D'Souza N, Hodges-Hoyland T; TIRID Consortium; Spiller OB, Kronenberg-Versteeg D, Szomolay B, van den Berg HA, Jones LC, Peakman M, Cole DK, Rizkallah PJ, Sewell AK. Dolton G, et al. J Clin Invest. 2024 Sep 17;134(18):e164535. doi: 10.1172/JCI164535. J Clin Invest. 2024. PMID: 39286976 Free PMC article.
• Innate and adaptive effector immune drivers of cytomegalovirus disease in lung transplantation: a double-edged sword.
  Bharti R, Calabrese DR. Bharti R, et al. Front Transplant. 2024 Jun 10;3:1388393. doi: 10.3389/frtra.2024.1388393. eCollection 2024. Front Transplant. 2024. PMID: 38993763 Free PMC article. Review.
• Can AlphaFold's breakthrough in protein structure help decode the fundamental principles of adaptive cellular immunity?
  McMaster B, Thorpe C, Ogg G, Deane CM, Koohy H. McMaster B, et al. Nat Methods. 2024 May;21(5):766-776. doi: 10.1038/s41592-024-02240-7. Epub 2024 Apr 23. Nat Methods. 2024. PMID: 38654083 Review.
• Is the exquisite specificity of lymphocytes generated by thymic selection or due to evolution?
  De Boer RJ, Kesmir C, Perelson AS, Borghans JAM. De Boer RJ, et al. Front Immunol. 2024 Mar 25;15:1266349. doi: 10.3389/fimmu.2024.1266349. eCollection 2024. Front Immunol. 2024. PMID: 38605941 Free PMC article.
• MORITS: An improved method to predict peptides from heterologous proteins that are recognized by the same T-cell receptor.
  Bruhn M, Spatz M, Kalinke U. Bruhn M, et al. Sci Rep. 2024 Apr 8;14(1):8255. doi: 10.1038/s41598-024-58350-x. Sci Rep. 2024. PMID: 38589549 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations